All In Biotech

Drug Trial Radar · NCT04503629

A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

A Phase 2,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Last checked: Nov 19, 2026Latest source record: Aug 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

Oct 9, 2018

Primary completion

May 17, 2019

Study completion May 17, 2019

Sponsor

Sponsor type
Industry
First posted
Aug 7, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 2,double-blinded, double dummy, parallel, positive drug, randomised controlled multicenter trial to evaluate efficacy and safety of 4 weeks treatment of Anaprazole 20mg QD, 40mg QD compared with rabeprazole 10mg QD in patients with duodenal ulcers.

Conditions

  • Duodenal Ulcer,DU

Interventions

  • Anaprazole SodiumDrug

    Anaprazole Sodium 20mg

  • Anaprazole SodiumDrug

    Anaprazole Sodium 40mg

  • Rabeprazole sodiumDrug

    Rabeprazole sodium 10mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The endoscopic healing rate of duodenal ulcers at week 4.Time frame: Treatment of 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Fisrst Affiliated Hospital of NanChang University

    Nanchang, Jiangxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.